Metabolic Syndrome in Early Chronic Obstructive Pulmonary Disease: Gender Differences and Impact on Exacerbation and Medical Costs

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2017 Available from: https://goldcopd.org. Accessed 92, 2017.
   Google Scholar
• Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med. 2010;7(3):e1000220.20305715
   PubMed Web of Science ®Google Scholar
• Patel AR, Hurst JR. Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. Expert Rev Respir Med. 2011;5(5):647–662. doi:10.1586/ers.11.6221955235
   PubMed Web of Science ®Google Scholar
• Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–969. doi:10.1183/09031936.0001240818579551
   PubMed Web of Science ®Google Scholar
• Mannino DM, Higuchi K, Yu TC, et al. Economic burden of COPD in the presence of comorbidities. Chest. 2015;148(1):138–150. doi:10.1378/chest.14-243425675282
   PubMed Web of Science ®Google Scholar
• Huber MB, Wacker ME, Vogelmeier CF, Leidl R. Excess costs of comorbidities in chronic obstructive pulmonary disease: a systematic review. PLoS One. 2015;10(4):e0123292. doi:10.1371/journal.pone.012329225875204
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–2752. doi:10.1161/CIRCULATIONAHA.105.16940416157765
   PubMed Web of Science ®Google Scholar
• Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA. 2015;313(19):1973–1974. doi:10.1001/jama.2015.426025988468
   PubMed Web of Science ®Google Scholar
• Cebron Lipovec N, Beijers RJ, van den Borst B, Doehner W, Lainscak M, Schols AM. The prevalence of metabolic syndrome in chronic obstructive pulmonary disease: a systematic review. COPD. 2016;13(3):399–406.26914392
   PubMedGoogle Scholar
• Minas M, Kostikas K, Papaioannou AI, et al. The association of metabolic syndrome with adipose tissue hormones and insulin resistance in patients with COPD without co-morbidities. COPD. 2011;8(6):414–420. doi:10.3109/15412555.2011.61960022149401
   PubMedGoogle Scholar
• Mekov E, Slavova Y, Tsakova A, et al. Metabolic syndrome in hospitalized patients with chronic obstructive pulmonary disease. Peer J. 2015;3:e1068. doi:10.7717/peerj.106826157632
   PubMed Web of Science ®Google Scholar
• Kupeli E, Ulubay G, Ulasli SS, Sahin T, Erayman Z, Gursoy A. Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study. Endocrine. 2010;38(1):76–82. doi:10.1007/s12020-010-9351-320960105
   PubMed Web of Science ®Google Scholar
• Lee S, Park HS, Kim SM, et al. Cut-off points of waist circumference for defining abdominal obesity in the Korean population. Korean J Obes. 2006;15(1):1–9.
   Google Scholar
• Tran BT, Jeong BY, Oh JK. The prevalence trend of metabolic syndrome and its components and risk factors in Korean adults: results from the Korean National Health and Nutrition Examination Survey 2008–2013. BMC Public Health. 2017;17(1):71. doi:10.1186/s12889-016-3936-628086850
   PubMed Web of Science ®Google Scholar
• Watz H, Waschki B, Kirsten A, et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest. 2009;136(4):1039–1046. doi:10.1378/chest.09-039319542257
   PubMed Web of Science ®Google Scholar
• Leone N, Courbon D, Thomas F, et al. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med. 2009;179(6):509–516. doi:10.1164/rccm.200807-1195OC19136371
   PubMed Web of Science ®Google Scholar
• Piazzolla G, Castrovilli A, Liotino V, et al. Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): the interplay among smoking, insulin resistance and vitamin D. PLoS One. 2017;12(10):e0186708. doi:10.1371/journal.pone.018670829065130
   PubMed Web of Science ®Google Scholar
• Clini E, Crisafulli E, Radaeli A, Malerba M. COPD and the metabolic syndrome: an intriguing association. Intern Emerg Med. 2013;8(4):283–289. doi:10.1007/s11739-011-0700-x21964838
   PubMed Web of Science ®Google Scholar
• Groenewegen KH, Postma DS, Hop WC, Wielders PL, Schlosser NJ, Wouters EF. Increased systemic inflammation is a risk factor for COPD exacerbations. Chest. 2008;133(2):350–357. doi:10.1378/chest.07-134218198263
   PubMed Web of Science ®Google Scholar
• Baffi CW, Wood L, Winnica D, et al. Metabolic Syndrome and the Lung. Chest. 2016;149(6):1525–1534. doi:10.1016/j.chest.2015.12.03426836925
   PubMed Web of Science ®Google Scholar
• Celli B, Vestbo J, Jenkins CR, et al. Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med. 2011;183(3):317–322. doi:10.1164/rccm.201004-0665OC20813884
   PubMed Web of Science ®Google Scholar
• Kilic H, Kokturk N, Sari G, Cakir M. Do females behave differently in COPD exacerbation? Int J Chron Obstruct Pulmon Dis. 2015;10:823–830. doi:10.2147/COPD.S7895225977604
   PubMed Web of Science ®Google Scholar
• Wells C, Baker E. Metabolic syndrome and European Respiratory Monograph 59: COPD and Comorbidity. Eur Res Monograph. 2013;59:117–134.
   Google Scholar
• National Health Insurance Service. Available from: http://www.nhis.or.kr/static/html/wbd/g/a/wbdga0101.html. Accessed 92, 2017.
   Google Scholar
• Terzano C, Colamesta V, Unim B, et al. Chronic obstructive pulmonary disease (COPD) exacerbation: impact of comorbidities on length and costs during hospitalization. Eur Rev Med Pharmacol Sci. 2017;21(16):3680–3689.28925473
   PubMed Web of Science ®Google Scholar
• Hong AR, Lim S. Clinical characteristics of metabolic syndrome in Korea, and its comparison with other Asian countries. J Diabetes Investig. 2015;6(5):508–515. doi:10.1111/jdi.2015.6.issue-5
   Web of Science ®Google Scholar
• Lim S, Shin H, Song JH, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998–2007. Diabetes Care. 2011;34(6):1323–1328. doi:10.2337/dc10-210921505206
   PubMed Web of Science ®Google Scholar